Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Harvard Business School
Healthtrust
Colorcon
Farmers Insurance

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021454

« Back to Dashboard

NDA 021454 describes TESTIM, which is a drug marketed by Auxilium Pharms Llc and is included in one NDA. It is available from two suppliers. There are ten patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TESTIM profile page.

The generic ingredient in TESTIM is testosterone. There are sixty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 021454
Tradename:TESTIM
Applicant:Auxilium Pharms Llc
Ingredient:testosterone
Patents:10
Formulation / Manufacturing:see details
Pharmacology for NDA: 021454
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 021454
Suppliers and Packaging for NDA: 021454
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TESTIM testosterone GEL;TRANSDERMAL 021454 NDA AUTHORIZED GENERIC Par Pharmaceutical, Inc. 0254-1012 0254-1012-11 30 TUBE in 1 CARTON (0254-1012-11) > 5 g in 1 TUBE
TESTIM testosterone GEL;TRANSDERMAL 021454 NDA Endo Pharmaceuticals, Inc. 66887-001 66887-001-05 30 TUBE in 1 CARTON (66887-001-05) > 5 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TRANSDERMALStrength50MG/5GM PACKET
Approval Date:Oct 31, 2002TE:AB2RLD:Yes
Patent:➤ Sign UpPatent Expiration:Jan 18, 2025Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD FOR ADMINISTRATION OF TESTOSTERONE
Patent:➤ Sign UpPatent Expiration:Apr 21, 2023Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD FOR ADMINISTRATION OF TESTOSTERONE
Patent:➤ Sign UpPatent Expiration:Apr 21, 2023Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD FOR ADMINISTRATION OF TESTOSTERONE

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
US Department of Justice
Teva
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.